Cutaneous leucocyte-associated antigen (CLA) molecules are differently expressed on CD4
+ and CD8
+ T cells during the clinical course of cutaneous leishmaniasis. Patients were evaluated during active cutaneous leishmaniasis (A-CL), after the end of therapy (early cured, ECCL), and 1 year after the end of therapy (late cured, LCCL). Healthy subjects (HS) were used as control negative cases. The percentage of cells presenting CLA molecules in blood lymphocytes was verified for both T CD4
+ (

) and T CD8
+ (

) either
ex-vivo (a, b) and after
in vitro stimulation with
Leishmania braziliensis antigens (Lb-Ag) (c,d). Each point represents one individual and bars represent the median of the results. *
P < 0·05; **
P < 0·01; ***
P < 0·001; n.s.: not significant.